Preoperative_prostate-specific_antigen_in_predicting_pathologic_stage_and_grade_after_radical_prostatectomy._Preoperative_serum_prostate-specific_antigen_(PSA)_was_measured_in_63_men_who_had_clinically_localized,_previously_untreated_adenocarcinoma_of_the_prostate_and_underwent_subsequent_radical_prostatectomy_and_bilateral_pelvic_lymph_node_dissection._Pathologic_stage_and_grade_were_correlated_to_the_serum_PSA_value._Patients_with_organ-confined_(P1,_P2)_and_extracapsular_(P3,_P3N_+)_prostate_cancer_had_elevated_preoperative_serum_PSA_levels_(greater_than_4_ng/mL)_in_61_and_90_percent_of_cases,_respectively._Patients_with_low-grade_and_high-grade_tumor_histology_had_elevated_preoperative_PSA_levels_in_62_and_80_percent_of_cases,_respectively._In_distinguishing_between_organ-confined_and_extracapsular_disease_with_a_preoperative_serum_PSA_of_10_ng/mL_as_a_cutoff_value,_the_sensitivity_was_68_percent,_the_specificity_was_66_percent,_the_positive_predictive_value_was_46_percent,_and_the_negative_predictive_value_was_83_percent._Although_there_was_a_trend_of_increasing_preoperative_serum_PSA_levels_with_higher_pathologic_stage_or_grade,_there_was_no_significant_difference_in_preoperative_serum_PSA_values_with_pathologic_stage_and/or_grade_considered_as_a_group_or_in_determining_stage_and/or_grade_preoperatively_on_an_individual_basis.